A. Rayamajhi, B. Acharya, and B. Khanal, “TP53 Mutation as Molecular Marker in the Assessment of Surgical Margin Status in Head and Neck Squamous Cell Carcinoma”, Nep. J. Cancer, vol. 5, no. 1, pp. 27–32, Sep. 2021.